4
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001851044-26-000003
EVP of R&D sold 26,269 shares at $1.56 ($40,980)
From the SEC's structured data for this filing
Trades in this filing
Roberts Zachary · EVP of R&D
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-21 | Sale : show line 1 in the form | −26,269 | $1.56 | $40,980 | 616,866 | D |
| Open-market sales · 26,269 sh · avg $1.56 · $40,980 | ||||||
Loading xslF345X05/wk-form4_1769202908.xml…